Recombinant human factor VII, while initially looking promising in intracerebral hemorrhage, failed to show benefit following further study and is no longer recommended.
O factor VII recombinante humano, aínda que inicialmente parecía prometedor en hemorraxias intracerebrais, non demostrou ser beneficioso en posteriores estudos e xa non se recomenda.